SCHEMBL19081489

SCHEMBL19081489

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5oc6cc7c(cc6c5c4)oc4cc5ccccc5cc47)cc3)c3ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.44
PLA2G4A P47712 4/20 0.44
ESR1 P03372 3/20 0.44
ESR2 Q92731 3/20 0.44
PLA2G10 O15496 1/20 0.40
PGR P06401 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
GAA P10253 1/20 0.39
KDM4E B2RXH2 3/20 0.38
MAPT P10636 3/20 0.38
HPGD P15428 3/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
GLA P06280 1/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CASP3 P42574 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16067581 0.98 PLA2G2A (0.46) PLA2G2APLA2G4AESR1ESR2PLA2G10
SCHEMBL16067702 0.98 PLA2G2A (0.46) PLA2G2APLA2G4AESR1ESR2PLA2G10
SCHEMBL25667899 0.98 PLA2G2A (0.46) PLA2G2APLA2G4AESR1ESR2PLA2G10
SCHEMBL22907992 0.95 ESR1 (0.45) PLA2G2APLA2G4AESR1ESR2PLA2G10
SCHEMBL16067652 0.95 ESR1 (0.45) PLA2G2APLA2G4AESR1ESR2PLA2G10
SCHEMBL31747799 0.95 ESR1 (0.45) PLA2G2APLA2G4AESR1ESR2PLA2G10
SCHEMBL24024569 0.94 PLA2G2A (0.43) PLA2G2APLA2G4AESR1ESR2PLA2G10
SCHEMBL19081476 0.94 PGR (0.44) PLA2G2APLA2G4AESR1ESR2PLA2G10
SCHEMBL16067687 0.94 PLA2G2A (0.44) PLA2G2APLA2G4AESR1ESR2PLA2G10
SCHEMBL16068035 0.94 PLA2G2A (0.44) PLA2G2APLA2G4AESR1ESR2PLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PLA2G2A 4330/4885PLA2G4A 4338/4885ESR1 225/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PLA2G2A 4330/4885PLA2G4A 4338/4885ESR1 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.